West Paces Advisors’s Hologic HOLX Stock Holding History

West Paces Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-34	Closed	-$1.36K	–	522
2016 Q4	$1.36K	Buy	+34	New	+$1.31K	﹤0.01%	506

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

West Paces Advisors's HOLX Position: Q1 2017 in Review

West Paces Advisors sold out of Hologic (HOLX) in Q1 2017, closing a stake of 34 shares — an estimated $1.36K sold.

West Paces Advisors first reported a position in HOLX in Q4 2016 and held it in 1 quarter. The position peaked at $1.36K in Q4 2016. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

West Paces Advisors reported no remaining Hologic position as of Q1 2017 after selling out during the quarter.
West Paces Advisors sold 34 Hologic shares in Q1 2017, an estimated $1.36K.
West Paces Advisors first reported a position in Hologic in Q4 2016 and held it in 1 quarter.
West Paces Advisors's Hologic position peaked at $1.36K in Q4 2016.
501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on West Paces Advisors's 13F filing for Q1 2017, filed 22 Dec 2023.